Home Categories Organic Chemistry Mycophenolate mofetil
A5440712

Mycophenolate mofetil , Analysis of standard products, ≥98% , 128794-94-5

CAS NO.:128794-94-5

Empirical Formula: C23H31NO7

Molecular Weight: 433.49

MDL number: MFCD00867568

Pack Size Price Stock Quantity
10MG RMB151.20 In Stock
others     Enquire
Update time: 2022-07-08

PRODUCT Properties

Melting point: 95-96°C
Boiling point: 637.6±55.0 °C(Predicted)
Density  1.222±0.06 g/cm3(Predicted)
storage temp.  room temp
solubility  DMSO: ≥15mg/mL
pka 5.6(at 25℃)
form  powder
color  white to beige
Merck  14,6327
Stability: Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.
InChIKey RTGDFNSFWBGLEC-SYZQJQIISA-N

Description and Uses

Mycophenolate mofetil was launched in 1995 in the U.S.A., its first market worldwide, for the prevention of acute kidney transplant rejection in conjunction with other immunosuppressive therapy and to treat refractory acute kidney graft rejection. With improved oral absorption and bioavailability, mycophenolate mofetil is a prodrug of mycophenolic acid (MPA), a fermentation product of several Penicillium species. MPA is a selective, reversible, non-competitive inhibitor of inosinate dehydrogenase and guanylate synthetase. It inhibits the de now pathway of purine biosynthesis. MPA was found to have more potent antiproliferative effects on T and B lymphocytes than other cell types. Compared with other immunosuppressants, mycophenolate mofetil is reportedly superior due to its unique mechanism of action and excellent safety profile for long term use. Mycophenolate mofetil is being investigated clinically in the treatment of heart and liver transplantation rejection, asthma, in preventing coronary artery restenosis, and in treating rheumatoid arthritis.

An immunosuppressant.

Safety

Symbol(GHS) 
GHS07,GHS08,GHS09
Signal word  Danger
Hazard statements  H302-H360D-H372-H410
Precautionary statements  P202-P260-P264-P273-P301+P312-P308+P313
Hazard Codes  Xn
Risk Statements  22
Safety Statements  22-24/25
RIDADR  UN 3077 9 / PGIII
WGK Germany  3
RTECS  MP7746700
HS Code  29349990

RELATED PRODUCTS